Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Equillium to Participate in the 2026 Jefferies Global Healthcare Conference

globenewswire.com
EQ Equillium is scheduled to participate in the 2026 Jefferies Global Healthcare Conference. The article does not provide any information about the company's performance or outlook.

Equillium to Participate in the 2026 Jefferies Global Healthcare Conference LA JOLLA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55pm EDT.

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

About Equillium

Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact

PJ Kelleher

LifeSci Advisors, LLC

+1-617-430-7579

pkelleher@lifesciadvisors.com